2022 annual financial data
Tango Therapeutics 2022 Net margin
Direct answer
Net margin was -435.14%.
Operating income was -111,071,000 USD and net income was -108,176,000 USD.
Operating cash flow was -109,080,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,860,000 USD
- Operating income
- -111,071,000 USD
- Net income
- -108,176,000 USD
- Operating cash flow
- -109,080,000 USD